Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) Stock Competitors & Peer Comparison
See (NATHBIOGEN.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Inputs Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NATHBIOGEN.NS | ₹148.05 | -0.60% | 2.8B | 6.52 | ₹22.69 | +1.35% |
| COROMANDEL.BO | ₹2,311.10 | +1.39% | 681.1B | 28.44 | ₹81.26 | +0.78% |
| COROMANDEL.NS | ₹2,311.00 | +1.35% | 681B | 28.48 | ₹81.14 | +0.78% |
| UPL.NS | ₹626.20 | -0.69% | 528.6B | 29.92 | ₹20.93 | +0.96% |
| FACT.NS | ₹756.80 | -0.06% | 489.7B | 1610.21 | ₹0.47 | +0.05% |
| FACT.BO | ₹755.90 | -0.24% | 489.1B | 1608.30 | ₹0.47 | +0.05% |
| PIIND.NS | ₹3,093.50 | -0.44% | 470.3B | 32.39 | ₹95.71 | +0.48% |
| PIIND.BO | ₹3,097.00 | -0.46% | 469.8B | 32.38 | ₹95.64 | +0.48% |
| BAYERCROP.NS | ₹4,727.90 | +0.35% | 212.5B | 31.74 | ₹148.94 | +2.64% |
| SUMICHEM.BO | ₹401.00 | -1.09% | 200.2B | 37.58 | ₹10.67 | +0.30% |
Stock Comparison
NATHBIOGEN.NS vs COROMANDEL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, COROMANDEL.BO has a market cap of 681.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while COROMANDEL.BO trades at ₹2,311.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas COROMANDEL.BO's P/E ratio is 28.44. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to COROMANDEL.BO's ROE of +0.21%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to COROMANDEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check COROMANDEL.BO's competition here
NATHBIOGEN.NS vs COROMANDEL.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, COROMANDEL.NS has a market cap of 681B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while COROMANDEL.NS trades at ₹2,311.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas COROMANDEL.NS's P/E ratio is 28.48. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to COROMANDEL.NS's ROE of +0.21%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to COROMANDEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check COROMANDEL.NS's competition here
NATHBIOGEN.NS vs UPL.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, UPL.NS has a market cap of 528.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while UPL.NS trades at ₹626.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas UPL.NS's P/E ratio is 29.92. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to UPL.NS's ROE of +0.05%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to UPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check UPL.NS's competition here
NATHBIOGEN.NS vs FACT.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, FACT.NS has a market cap of 489.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while FACT.NS trades at ₹756.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas FACT.NS's P/E ratio is 1610.21. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to FACT.NS's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to FACT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check FACT.NS's competition here
NATHBIOGEN.NS vs FACT.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, FACT.BO has a market cap of 489.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while FACT.BO trades at ₹755.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas FACT.BO's P/E ratio is 1608.30. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to FACT.BO's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to FACT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check FACT.BO's competition here
NATHBIOGEN.NS vs PIIND.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, PIIND.NS has a market cap of 470.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while PIIND.NS trades at ₹3,093.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas PIIND.NS's P/E ratio is 32.39. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PIIND.NS's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PIIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PIIND.NS's competition here
NATHBIOGEN.NS vs PIIND.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, PIIND.BO has a market cap of 469.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while PIIND.BO trades at ₹3,097.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas PIIND.BO's P/E ratio is 32.38. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PIIND.BO's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PIIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PIIND.BO's competition here
NATHBIOGEN.NS vs BAYERCROP.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BAYERCROP.NS has a market cap of 212.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BAYERCROP.NS trades at ₹4,727.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BAYERCROP.NS's P/E ratio is 31.74. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BAYERCROP.NS's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BAYERCROP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BAYERCROP.NS's competition here
NATHBIOGEN.NS vs SUMICHEM.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SUMICHEM.BO has a market cap of 200.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SUMICHEM.BO trades at ₹401.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SUMICHEM.BO's P/E ratio is 37.58. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SUMICHEM.BO's ROE of +0.18%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SUMICHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SUMICHEM.BO's competition here
NATHBIOGEN.NS vs SUMICHEM.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SUMICHEM.NS has a market cap of 199.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SUMICHEM.NS trades at ₹400.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SUMICHEM.NS's P/E ratio is 37.64. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SUMICHEM.NS's ROE of +0.18%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SUMICHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SUMICHEM.NS's competition here
NATHBIOGEN.NS vs CHAMBLFERT.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, CHAMBLFERT.BO has a market cap of 183.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while CHAMBLFERT.BO trades at ₹459.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas CHAMBLFERT.BO's P/E ratio is 9.88. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to CHAMBLFERT.BO's ROE of +0.22%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to CHAMBLFERT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check CHAMBLFERT.BO's competition here
NATHBIOGEN.NS vs CHAMBLFERT.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, CHAMBLFERT.NS has a market cap of 183.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while CHAMBLFERT.NS trades at ₹458.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas CHAMBLFERT.NS's P/E ratio is 9.61. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to CHAMBLFERT.NS's ROE of +0.22%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to CHAMBLFERT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check CHAMBLFERT.NS's competition here
NATHBIOGEN.NS vs ATUL7.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, ATUL7.BO has a market cap of 179B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while ATUL7.BO trades at ₹7,100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas ATUL7.BO's P/E ratio is N/A. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ATUL7.BO's ROE of +0.10%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to ATUL7.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ATUL7.BO's competition here
NATHBIOGEN.NS vs EIDPARRY.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, EIDPARRY.BO has a market cap of 154B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while EIDPARRY.BO trades at ₹865.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas EIDPARRY.BO's P/E ratio is 13.38. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to EIDPARRY.BO's ROE of +0.11%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to EIDPARRY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check EIDPARRY.BO's competition here
NATHBIOGEN.NS vs SHARDACROP.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SHARDACROP.NS has a market cap of 107.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SHARDACROP.NS trades at ₹1,189.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SHARDACROP.NS's P/E ratio is 18.95. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SHARDACROP.NS's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SHARDACROP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SHARDACROP.NS's competition here
NATHBIOGEN.NS vs SHARDACROP.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SHARDACROP.BO has a market cap of 107.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SHARDACROP.BO trades at ₹1,188.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SHARDACROP.BO's P/E ratio is 18.95. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SHARDACROP.BO's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SHARDACROP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SHARDACROP.BO's competition here
NATHBIOGEN.NS vs PARADEEP.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, PARADEEP.NS has a market cap of 95B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while PARADEEP.NS trades at ₹116.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas PARADEEP.NS's P/E ratio is 11.47. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PARADEEP.NS's ROE of +0.20%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PARADEEP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PARADEEP.NS's competition here
NATHBIOGEN.NS vs PARADEEP.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, PARADEEP.BO has a market cap of 95B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while PARADEEP.BO trades at ₹116.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas PARADEEP.BO's P/E ratio is 11.47. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PARADEEP.BO's ROE of +0.20%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PARADEEP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PARADEEP.BO's competition here
NATHBIOGEN.NS vs RCF.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, RCF.BO has a market cap of 71B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while RCF.BO trades at ₹128.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas RCF.BO's P/E ratio is 22.75. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RCF.BO's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to RCF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RCF.BO's competition here
NATHBIOGEN.NS vs RCF.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, RCF.NS has a market cap of 71B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while RCF.NS trades at ₹128.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas RCF.NS's P/E ratio is 22.71. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RCF.NS's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to RCF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RCF.NS's competition here
NATHBIOGEN.NS vs GSFC.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, GSFC.BO has a market cap of 68.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while GSFC.BO trades at ₹171.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas GSFC.BO's P/E ratio is 10.24. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to GSFC.BO's ROE of +0.06%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to GSFC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check GSFC.BO's competition here
NATHBIOGEN.NS vs GSFC.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, GSFC.NS has a market cap of 68.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while GSFC.NS trades at ₹171.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas GSFC.NS's P/E ratio is 9.86. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to GSFC.NS's ROE of +0.06%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to GSFC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check GSFC.NS's competition here
NATHBIOGEN.NS vs PICCADIL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, PICCADIL.BO has a market cap of 56.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while PICCADIL.BO trades at ₹573.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas PICCADIL.BO's P/E ratio is 41.59. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PICCADIL.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PICCADIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PICCADIL.BO's competition here
NATHBIOGEN.NS vs RALLIS.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, RALLIS.NS has a market cap of 53.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while RALLIS.NS trades at ₹276.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas RALLIS.NS's P/E ratio is 32.23. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RALLIS.NS's ROE of +0.09%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to RALLIS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RALLIS.NS's competition here
NATHBIOGEN.NS vs RALLIS.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, RALLIS.BO has a market cap of 53.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while RALLIS.BO trades at ₹276.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas RALLIS.BO's P/E ratio is 32.23. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RALLIS.BO's ROE of +0.09%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to RALLIS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RALLIS.BO's competition here
NATHBIOGEN.NS vs DHANUKA.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, DHANUKA.BO has a market cap of 48.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while DHANUKA.BO trades at ₹1,073.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas DHANUKA.BO's P/E ratio is 6.87. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to DHANUKA.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to DHANUKA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check DHANUKA.BO's competition here
NATHBIOGEN.NS vs DHANUKA.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, DHANUKA.NS has a market cap of 48.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while DHANUKA.NS trades at ₹1,068.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas DHANUKA.NS's P/E ratio is 6.83. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to DHANUKA.NS's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to DHANUKA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check DHANUKA.NS's competition here
NATHBIOGEN.NS vs KSCL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, KSCL.BO has a market cap of 41.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while KSCL.BO trades at ₹804.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas KSCL.BO's P/E ratio is 13.65. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KSCL.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to KSCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KSCL.BO's competition here
NATHBIOGEN.NS vs MBAPL.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MBAPL.NS has a market cap of 40.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MBAPL.NS trades at ₹461.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MBAPL.NS's P/E ratio is 38.62. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MBAPL.NS's ROE of +0.26%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MBAPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MBAPL.NS's competition here
NATHBIOGEN.NS vs NFL.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NFL.NS has a market cap of 38.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NFL.NS trades at ₹78.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NFL.NS's P/E ratio is 19.72. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NFL.NS's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to NFL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NFL.NS's competition here
NATHBIOGEN.NS vs NFL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NFL.BO has a market cap of 38.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NFL.BO trades at ₹78.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NFL.BO's P/E ratio is 19.70. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NFL.BO's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to NFL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NFL.BO's competition here
NATHBIOGEN.NS vs MANGCHEFER.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MANGCHEFER.NS has a market cap of 36.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MANGCHEFER.NS trades at ₹308.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MANGCHEFER.NS's P/E ratio is 22.67. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MANGCHEFER.NS's ROE of +0.16%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to MANGCHEFER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MANGCHEFER.NS's competition here
NATHBIOGEN.NS vs MANGCHEFER.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MANGCHEFER.BO has a market cap of 36.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MANGCHEFER.BO trades at ₹308.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MANGCHEFER.BO's P/E ratio is 22.63. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MANGCHEFER.BO's ROE of +0.16%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to MANGCHEFER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MANGCHEFER.BO's competition here
NATHBIOGEN.NS vs CIANAGRO.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, CIANAGRO.BO has a market cap of 35.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while CIANAGRO.BO trades at ₹1,283.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas CIANAGRO.BO's P/E ratio is 31.96. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to CIANAGRO.BO's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to CIANAGRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check CIANAGRO.BO's competition here
NATHBIOGEN.NS vs BNHOLDINGS.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BNHOLDINGS.BO has a market cap of 34.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BNHOLDINGS.BO trades at ₹355.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BNHOLDINGS.BO's P/E ratio is 26.71. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BNHOLDINGS.BO's ROE of +0.18%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BNHOLDINGS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BNHOLDINGS.BO's competition here
NATHBIOGEN.NS vs KRISHANA.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, KRISHANA.NS has a market cap of 30.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while KRISHANA.NS trades at ₹494.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas KRISHANA.NS's P/E ratio is 23.51. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KRISHANA.NS's ROE of +0.34%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to KRISHANA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KRISHANA.NS's competition here
NATHBIOGEN.NS vs BHAGCHEM.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BHAGCHEM.BO has a market cap of 26.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BHAGCHEM.BO trades at ₹205.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BHAGCHEM.BO's P/E ratio is 205.85. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHAGCHEM.BO's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BHAGCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHAGCHEM.BO's competition here
NATHBIOGEN.NS vs BHAGCHEM.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BHAGCHEM.NS has a market cap of 26.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BHAGCHEM.NS trades at ₹204.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BHAGCHEM.NS's P/E ratio is 200.62. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHAGCHEM.NS's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BHAGCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHAGCHEM.NS's competition here
NATHBIOGEN.NS vs NACLIND.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NACLIND.NS has a market cap of 26B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NACLIND.NS trades at ₹132.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NACLIND.NS's P/E ratio is -65.40. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NACLIND.NS's ROE of -0.10%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NACLIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NACLIND.NS's competition here
NATHBIOGEN.NS vs NACLIND.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NACLIND.BO has a market cap of 26B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NACLIND.BO trades at ₹132.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NACLIND.BO's P/E ratio is -65.32. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NACLIND.BO's ROE of -0.10%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NACLIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NACLIND.BO's competition here
NATHBIOGEN.NS vs VENKYS.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, VENKYS.BO has a market cap of 24.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while VENKYS.BO trades at ₹1,714.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas VENKYS.BO's P/E ratio is -57.49. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to VENKYS.BO's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to VENKYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check VENKYS.BO's competition here
NATHBIOGEN.NS vs KSE.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, KSE.NS has a market cap of 22.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while KSE.NS trades at ₹697.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas KSE.NS's P/E ratio is N/A. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KSE.NS's ROE of +0.41%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to KSE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KSE.NS's competition here
NATHBIOGEN.NS vs INSECTICID.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, INSECTICID.BO has a market cap of 18.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while INSECTICID.BO trades at ₹630.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas INSECTICID.BO's P/E ratio is 12.93. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INSECTICID.BO's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to INSECTICID.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INSECTICID.BO's competition here
NATHBIOGEN.NS vs INSECTICID.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, INSECTICID.NS has a market cap of 18.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while INSECTICID.NS trades at ₹629.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas INSECTICID.NS's P/E ratio is 12.91. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INSECTICID.NS's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to INSECTICID.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INSECTICID.NS's competition here
NATHBIOGEN.NS vs IPL.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, IPL.NS has a market cap of 18B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while IPL.NS trades at ₹155.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas IPL.NS's P/E ratio is 16.38. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to IPL.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to IPL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check IPL.NS's competition here
NATHBIOGEN.NS vs IPL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, IPL.BO has a market cap of 17.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while IPL.BO trades at ₹155.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas IPL.BO's P/E ratio is 16.34. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to IPL.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to IPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check IPL.BO's competition here
NATHBIOGEN.NS vs SPIC.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SPIC.BO has a market cap of 14.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SPIC.BO trades at ₹69.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SPIC.BO's P/E ratio is 7.61. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SPIC.BO's ROE of +0.17%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SPIC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SPIC.BO's competition here
NATHBIOGEN.NS vs SPIC.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SPIC.NS has a market cap of 14.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SPIC.NS trades at ₹69.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SPIC.NS's P/E ratio is 7.02. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SPIC.NS's ROE of +0.17%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SPIC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SPIC.NS's competition here
NATHBIOGEN.NS vs ASTEC.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, ASTEC.NS has a market cap of 13.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while ASTEC.NS trades at ₹620.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas ASTEC.NS's P/E ratio is -14.68. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ASTEC.NS's ROE of -0.30%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to ASTEC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ASTEC.NS's competition here
NATHBIOGEN.NS vs ASTEC.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, ASTEC.BO has a market cap of 13.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while ASTEC.BO trades at ₹619.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas ASTEC.BO's P/E ratio is -14.66. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ASTEC.BO's ROE of -0.30%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to ASTEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ASTEC.BO's competition here
NATHBIOGEN.NS vs MOL.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MOL.NS has a market cap of 13.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MOL.NS trades at ₹52.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MOL.NS's P/E ratio is 32.96. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MOL.NS's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to MOL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MOL.NS's competition here
NATHBIOGEN.NS vs MOL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MOL.BO has a market cap of 13.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MOL.BO trades at ₹52.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MOL.BO's P/E ratio is 32.94. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MOL.BO's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to MOL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MOL.BO's competition here
NATHBIOGEN.NS vs BHARATRAS.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BHARATRAS.BO has a market cap of 12.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BHARATRAS.BO trades at ₹1,520.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BHARATRAS.BO's P/E ratio is 18.95. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHARATRAS.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BHARATRAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHARATRAS.BO's competition here
NATHBIOGEN.NS vs BHARATRAS.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BHARATRAS.NS has a market cap of 12.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BHARATRAS.NS trades at ₹1,520.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BHARATRAS.NS's P/E ratio is 19.03. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHARATRAS.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BHARATRAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHARATRAS.NS's competition here
NATHBIOGEN.NS vs MADRASFERT.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MADRASFERT.NS has a market cap of 11.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MADRASFERT.NS trades at ₹69.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MADRASFERT.NS's P/E ratio is 14.10. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MADRASFERT.NS's ROE of -0.31%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MADRASFERT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MADRASFERT.NS's competition here
NATHBIOGEN.NS vs MADRASFERT.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MADRASFERT.BO has a market cap of 11.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MADRASFERT.BO trades at ₹69.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MADRASFERT.BO's P/E ratio is 14.05. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MADRASFERT.BO's ROE of -0.31%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MADRASFERT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MADRASFERT.BO's competition here
NATHBIOGEN.NS vs ZUARI.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, ZUARI.NS has a market cap of 9.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while ZUARI.NS trades at ₹224.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas ZUARI.NS's P/E ratio is 0.98. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ZUARI.NS's ROE of +0.41%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to ZUARI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ZUARI.NS's competition here
NATHBIOGEN.NS vs BSHSL.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BSHSL.NS has a market cap of 9.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BSHSL.NS trades at ₹89.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BSHSL.NS's P/E ratio is 33.57. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BSHSL.NS's ROE of +0.25%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BSHSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BSHSL.NS's competition here
NATHBIOGEN.NS vs BLUECLOUDS.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BLUECLOUDS.BO has a market cap of 9.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BLUECLOUDS.BO trades at ₹20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BLUECLOUDS.BO's P/E ratio is 15.09. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BLUECLOUDS.BO's ROE of +0.49%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BLUECLOUDS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BLUECLOUDS.BO's competition here
NATHBIOGEN.NS vs BAJAJST.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BAJAJST.BO has a market cap of 8.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BAJAJST.BO trades at ₹420.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BAJAJST.BO's P/E ratio is 16.78. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BAJAJST.BO's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BAJAJST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BAJAJST.BO's competition here
NATHBIOGEN.NS vs HERANBA.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, HERANBA.BO has a market cap of 8.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while HERANBA.BO trades at ₹208.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas HERANBA.BO's P/E ratio is -13.88. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to HERANBA.BO's ROE of -0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to HERANBA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check HERANBA.BO's competition here
NATHBIOGEN.NS vs HERANBA.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, HERANBA.NS has a market cap of 8.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while HERANBA.NS trades at ₹208.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas HERANBA.NS's P/E ratio is -13.84. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to HERANBA.NS's ROE of -0.07%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to HERANBA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check HERANBA.NS's competition here
NATHBIOGEN.NS vs DHARMAJ.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, DHARMAJ.BO has a market cap of 8.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while DHARMAJ.BO trades at ₹240.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas DHARMAJ.BO's P/E ratio is 16.89. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to DHARMAJ.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to DHARMAJ.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check DHARMAJ.BO's competition here
NATHBIOGEN.NS vs DHARMAJ.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, DHARMAJ.NS has a market cap of 8.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while DHARMAJ.NS trades at ₹240.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas DHARMAJ.NS's P/E ratio is 16.87. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to DHARMAJ.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to DHARMAJ.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check DHARMAJ.NS's competition here
NATHBIOGEN.NS vs KSE.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, KSE.BO has a market cap of 6.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while KSE.BO trades at ₹213.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas KSE.BO's P/E ratio is 5.37. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KSE.BO's ROE of +0.41%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to KSE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KSE.BO's competition here
NATHBIOGEN.NS vs SHINDL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SHINDL.BO has a market cap of 6.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SHINDL.BO trades at ₹154.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SHINDL.BO's P/E ratio is 49.16. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SHINDL.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SHINDL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SHINDL.BO's competition here
NATHBIOGEN.NS vs BESTAGRO.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BESTAGRO.BO has a market cap of 6.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BESTAGRO.BO trades at ₹17.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BESTAGRO.BO's P/E ratio is 9.06. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BESTAGRO.BO's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BESTAGRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BESTAGRO.BO's competition here
NATHBIOGEN.NS vs BESTAGRO.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BESTAGRO.NS has a market cap of 6.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BESTAGRO.NS trades at ₹17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BESTAGRO.NS's P/E ratio is 9.05. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BESTAGRO.NS's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BESTAGRO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BESTAGRO.NS's competition here
NATHBIOGEN.NS vs SVRL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SVRL.BO has a market cap of 5.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SVRL.BO trades at ₹260.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SVRL.BO's P/E ratio is 22.77. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SVRL.BO's ROE of +0.21%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SVRL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SVRL.BO's competition here
NATHBIOGEN.NS vs KHAICHEM.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, KHAICHEM.NS has a market cap of 5.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while KHAICHEM.NS trades at ₹57.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas KHAICHEM.NS's P/E ratio is 7.72. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KHAICHEM.NS's ROE of +0.32%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to KHAICHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KHAICHEM.NS's competition here
NATHBIOGEN.NS vs KHAICHEM.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, KHAICHEM.BO has a market cap of 5.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while KHAICHEM.BO trades at ₹57.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas KHAICHEM.BO's P/E ratio is 7.70. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KHAICHEM.BO's ROE of +0.32%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to KHAICHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KHAICHEM.BO's competition here
NATHBIOGEN.NS vs MISHTANN.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MISHTANN.BO has a market cap of 4.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MISHTANN.BO trades at ₹4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MISHTANN.BO's P/E ratio is 1.39. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MISHTANN.BO's ROE of +0.35%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to MISHTANN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MISHTANN.BO's competition here
NATHBIOGEN.NS vs RAMAPHO.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, RAMAPHO.NS has a market cap of 4.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while RAMAPHO.NS trades at ₹127.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas RAMAPHO.NS's P/E ratio is 8.58. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RAMAPHO.NS's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to RAMAPHO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RAMAPHO.NS's competition here
NATHBIOGEN.NS vs RAMAPHO.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, RAMAPHO.BO has a market cap of 4.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while RAMAPHO.BO trades at ₹127.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas RAMAPHO.BO's P/E ratio is 8.57. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RAMAPHO.BO's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to RAMAPHO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RAMAPHO.BO's competition here
NATHBIOGEN.NS vs ARIES.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, ARIES.NS has a market cap of 4.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while ARIES.NS trades at ₹337.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas ARIES.NS's P/E ratio is 11.58. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ARIES.NS's ROE of +0.15%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to ARIES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ARIES.NS's competition here
NATHBIOGEN.NS vs SHIVALIK.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SHIVALIK.NS has a market cap of 4.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SHIVALIK.NS trades at ₹273.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SHIVALIK.NS's P/E ratio is 30.82. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SHIVALIK.NS's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SHIVALIK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SHIVALIK.NS's competition here
NATHBIOGEN.NS vs IGCL.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, IGCL.NS has a market cap of 4.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while IGCL.NS trades at ₹64.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas IGCL.NS's P/E ratio is 11.76. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to IGCL.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to IGCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check IGCL.NS's competition here
NATHBIOGEN.NS vs MODINATUR.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MODINATUR.BO has a market cap of 4.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MODINATUR.BO trades at ₹305.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MODINATUR.BO's P/E ratio is 11.10. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MODINATUR.BO's ROE of +0.32%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MODINATUR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MODINATUR.BO's competition here
NATHBIOGEN.NS vs KINGSINFR.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, KINGSINFR.BO has a market cap of 3.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while KINGSINFR.BO trades at ₹135.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas KINGSINFR.BO's P/E ratio is 22.90. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KINGSINFR.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to KINGSINFR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KINGSINFR.BO's competition here
NATHBIOGEN.NS vs GOODRICKE.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, GOODRICKE.BO has a market cap of 3.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while GOODRICKE.BO trades at ₹151.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas GOODRICKE.BO's P/E ratio is 18.02. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to GOODRICKE.BO's ROE of +0.06%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to GOODRICKE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check GOODRICKE.BO's competition here
NATHBIOGEN.NS vs NATHBIOGEN.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NATHBIOGEN.BO has a market cap of 2.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NATHBIOGEN.BO trades at ₹149.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NATHBIOGEN.BO's P/E ratio is 6.58. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NATHBIOGEN.BO's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to NATHBIOGEN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NATHBIOGEN.BO's competition here
NATHBIOGEN.NS vs INDOUS.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, INDOUS.NS has a market cap of 2.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while INDOUS.NS trades at ₹136.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas INDOUS.NS's P/E ratio is 18.51. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INDOUS.NS's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to INDOUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INDOUS.NS's competition here
NATHBIOGEN.NS vs INDOUS.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, INDOUS.BO has a market cap of 2.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while INDOUS.BO trades at ₹136.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas INDOUS.BO's P/E ratio is 18.45. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INDOUS.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to INDOUS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INDOUS.BO's competition here
NATHBIOGEN.NS vs NOVAAGRI.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NOVAAGRI.NS has a market cap of 2.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NOVAAGRI.NS trades at ₹29.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NOVAAGRI.NS's P/E ratio is 15.44. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NOVAAGRI.NS's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to NOVAAGRI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NOVAAGRI.NS's competition here
NATHBIOGEN.NS vs NAGAFERT.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NAGAFERT.BO has a market cap of 2.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NAGAFERT.BO trades at ₹4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NAGAFERT.BO's P/E ratio is -110.75. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NAGAFERT.BO's ROE of N/A. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to NAGAFERT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NAGAFERT.BO's competition here
NATHBIOGEN.NS vs NAGAFERT.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NAGAFERT.NS has a market cap of 2.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NAGAFERT.NS trades at ₹4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NAGAFERT.NS's P/E ratio is -146.33. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NAGAFERT.NS's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to NAGAFERT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NAGAFERT.NS's competition here
NATHBIOGEN.NS vs EQUIPPP.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, EQUIPPP.BO has a market cap of 1.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while EQUIPPP.BO trades at ₹18.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas EQUIPPP.BO's P/E ratio is 265.43. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to EQUIPPP.BO's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to EQUIPPP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check EQUIPPP.BO's competition here
NATHBIOGEN.NS vs EQUIPPP.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, EQUIPPP.NS has a market cap of 1.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while EQUIPPP.NS trades at ₹17.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas EQUIPPP.NS's P/E ratio is 250.00. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to EQUIPPP.NS's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to EQUIPPP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check EQUIPPP.NS's competition here
NATHBIOGEN.NS vs SPTRSHI.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SPTRSHI.BO has a market cap of 1.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SPTRSHI.BO trades at ₹44.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SPTRSHI.BO's P/E ratio is 51.13. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SPTRSHI.BO's ROE of +0.25%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SPTRSHI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SPTRSHI.BO's competition here
NATHBIOGEN.NS vs SBECSUG.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SBECSUG.BO has a market cap of 1.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SBECSUG.BO trades at ₹31.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SBECSUG.BO's P/E ratio is -5.86. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SBECSUG.BO's ROE of +0.33%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SBECSUG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SBECSUG.BO's competition here
NATHBIOGEN.NS vs MSL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, MSL.BO has a market cap of 1.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while MSL.BO trades at ₹132.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas MSL.BO's P/E ratio is 14.01. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MSL.BO's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to MSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MSL.BO's competition here
NATHBIOGEN.NS vs VIJSOLX.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, VIJSOLX.BO has a market cap of 1.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while VIJSOLX.BO trades at ₹444.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas VIJSOLX.BO's P/E ratio is 8.17. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to VIJSOLX.BO's ROE of +0.04%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to VIJSOLX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check VIJSOLX.BO's competition here
NATHBIOGEN.NS vs SSLEL.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, SSLEL.BO has a market cap of 1.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while SSLEL.BO trades at ₹260.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas SSLEL.BO's P/E ratio is -5.75. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SSLEL.BO's ROE of +0.11%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SSLEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SSLEL.BO's competition here
NATHBIOGEN.NS vs BHARATAGRI.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BHARATAGRI.BO has a market cap of 1.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BHARATAGRI.BO trades at ₹25.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BHARATAGRI.BO's P/E ratio is 159.44. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHARATAGRI.BO's ROE of -0.04%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BHARATAGRI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHARATAGRI.BO's competition here
NATHBIOGEN.NS vs INDSUCR.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, INDSUCR.BO has a market cap of 1.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while INDSUCR.BO trades at ₹73.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas INDSUCR.BO's P/E ratio is 3.31. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INDSUCR.BO's ROE of +0.17%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to INDSUCR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INDSUCR.BO's competition here
NATHBIOGEN.NS vs NARMADA.NS Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NARMADA.NS has a market cap of 1.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NARMADA.NS trades at ₹32.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NARMADA.NS's P/E ratio is 81.82. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NARMADA.NS's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NARMADA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NARMADA.NS's competition here
NATHBIOGEN.NS vs NARMADA.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, NARMADA.BO has a market cap of 1.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while NARMADA.BO trades at ₹32.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas NARMADA.BO's P/E ratio is 81.15. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NARMADA.BO's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NARMADA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NARMADA.BO's competition here
NATHBIOGEN.NS vs BNALTD.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, BNALTD.BO has a market cap of 1.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while BNALTD.BO trades at ₹380.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas BNALTD.BO's P/E ratio is 12.56. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BNALTD.BO's ROE of +0.04%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BNALTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BNALTD.BO's competition here
NATHBIOGEN.NS vs PARVATI.BO Comparison February 2026
NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NATHBIOGEN.NS stands at 2.8B. In comparison, PARVATI.BO has a market cap of 1.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹148.05, while PARVATI.BO trades at ₹7.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NATHBIOGEN.NS currently has a P/E ratio of 6.52, whereas PARVATI.BO's P/E ratio is -18.30. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PARVATI.BO's ROE of -0.09%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to PARVATI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PARVATI.BO's competition here